Crinetics Pharmaceuticals... (CRNX)
NASDAQ: CRNX
· Real-Time Price · USD
28.96
-0.47 (-1.60%)
At close: Aug 20, 2025, 10:56 AM
-1.60% (1D)
| Bid | 28.94 |
| Market Cap | 2.73B |
| Revenue (ttm) | 760K |
| Net Income (ttm) | -328.25M |
| EPS (ttm) | -4.1 |
| PE Ratio (ttm) | -7.06 |
| Forward PE | -5.85 |
| Analyst | Buy |
| Ask | 29.04 |
| Volume | 118,677 |
| Avg. Volume (20D) | 822,261 |
| Open | 29.52 |
| Previous Close | 29.43 |
| Day's Range | 28.95 - 29.64 |
| 52-Week Range | 24.10 - 62.53 |
| Beta | 0.33 |
About CRNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Crinetics Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-3.69%
CRNX stock has given up its prior gain. Crinetics ...
Unlock content with
Pro Subscription
1 week ago
-3.69%
Crinetics Pharmaceuticals shares are trading higher after the company reported a Q2 revenue beat and announced the Palsonify NDA is on track.
